Dr David Shindler has been appointed executive director of BioDiscovery Toronto, a collection of two universities and seven research hospitals located in the MaRS Discovery District. He will be responsible for leading efforts to maximize commercialization of research emanating from member institutions by linking the research, industry and financial communities. Shindler was previously president and CEO of Milestone Medica Corp, one of several early-stage venture capital funds associated with Royal Bank Technology Ventures. Prior to that, he was senior executive and commercial director of the Canadi